Latest News for: gbm

Edit

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (BioLineRX Ltd)

Public Technologies 28 Apr 2026
). The text version of this document is not available ... Disclaimer. BioLineRX Ltd.
Edit

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (Form 6-K) (BioLineRX Ltd)

Public Technologies 28 Apr 2026
the Treatment of Glioblastoma (GBM) ... GBM remains one of the most aggressive and treatment-resistant cancers, and there is an urgent need for breakthrough innovation and more effective treatment options.
Edit

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

PR Newswire 28 Apr 2026
... (GBM) and other high-grade gliomas ... GBM remains one of the most aggressive and treatment-resistant cancers, and there is an urgent need for breakthrough innovation and more effective treatment options.
Edit

GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial

Billings Gazette 09 Apr 2026
Tinostamustine Now Enrolling in GBM AGILE, a Registrational-Intent Phase 2/3 Adaptive Platform Trial for Patients with Glioblastoma ... .
Edit

GBM Bahrain appoints Ashesh Mukhopadhyay as General Manager

bizbahrain 04 Apr 2026
Gulf Business Machines (GBM), an end-to-end digital solutions provider, today announced the appointment of Ashesh Mukhopadhyay as the General Manager for its Bahrain operations ... Marwan Faraj Bin Hamoodah, Chairman of GBM, said.
Edit

Glioblastoma Multiforme (GBM) Treatment Market to Grow by $1.44 Billion During 2026-2030: Strategic Analysis of ...

Nasdaq Globe Newswire 02 Apr 2026
Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The ...
Edit

Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (BioLineRX Ltd)

Public Technologies 26 Mar 2026
). The text version of this document is not available ... Disclaimer. BioLineRX Ltd.
Edit

BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (Form 6-K) (BioLineRX Ltd)

Public Technologies 26 Mar 2026
Glioblastoma (GBM) ... GLIX1 has demonstrated potent anti-tumor activity in multiple GBM models, excellent blood-brain ... The Phase 1 part of the trial is expected to recruit up to 30 patients with recurrent and progressive GBM and other high-grade glioma.
Edit

BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

PR Newswire 26 Mar 2026
GLIX1 has demonstrated potent anti-tumor activity in multiple GBM models, excellent blood-brain barrier penetration and a favorable safety profile in preclinical toxicology studies ... GBM was selected as ...
Edit

Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial

Burlington Times-News 25 Mar 2026
... Fund (FCIF) to support the company's STAR-GBM .
Edit

INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

PR Newswire 04 Mar 2026
In an ongoing Phase 2 trial in newly diagnosed GBM patients, INO-5401 plus INO-9012 in combination with a PD-1 checkpoint inhibitor elicited robust immune responses that potentially correlate with enhanced survival.
Edit

NOTICE NO. 1/GBM/2026 – ESTABLISHES THE MOZAMBIQUE INSTANT PAYMENT SYSTEM AND APPROVES ITS REGULATION (Bank of Mozambique)

Public Technologies 27 Feb 2026
). The Banco de Moçambique has issued Notice No. 1/GBM/2026, of 25 February, establishing the Mozambique Instant Payment System and approving the Regulation thereof ... Attachments Original document Permalink. Disclaimer.
Edit

BADEA WINS FINANCIAL INSTITUTIONS BOND DEAL OF THE YEARAT GBM AWARDS:AFRICA 2026 RECOGNITION FOR €750M 3-YEAR SENIORUNSECURED NOTES TRANSACTION (Arab Bank for Economic Development in Africa)

Public Technologies 19 Feb 2026
BADEA WINS FINANCIAL INSTITUTIONS BOND DEAL OF THE YEAR AT GBM AWARDS. ... Notes has been awarded "Financial Institutions Bond Deal of the Year" at the Global Banking & Markets (GBM) Awards.
Edit

Diakonos Oncology Announces Study to Continue after First DSMB Safety Review of DOC1021 in Phase 2 GBM Study

PR Newswire 17 Feb 2026
Independent Data Safety Monitoring Board recommends continuation of Phase 2 GBM trial without modification ... The company also received Orphan Drug Designation for the GBM program in January 2024.
Edit

Amid confusion, city water company proposal put on hold at HDMC meet; special GBM on ...

The Times of India 31 Jan 2026
Comments. +Text SizeSmallMediumLarge. .

Article Search

tools
×
×
×
×